Sweden· SE-20200724000025
Voxzogo 0,56 mg Pulver och vätska till injektionsvätska, lösning
A medicinal product containing vosoritide, registered in Sweden by BioMarin International Limited.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Vosoritide
- Manufacturer
- BioMarin International Limited
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20200724000025
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vosoritide in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumVoxzogo 0.56 mgBioMarin International
- SwitzerlandVoxzogo 0.56 mg, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungDRAC AG
- SpainVOXZOGO 0,56 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLEBiomarin International Limited
- IcelandVoxzogoBioMarin International Limited
- PolandVoxzogoBioMarin International Ltd.
- NetherlandsVoxzogo 0,4 mg, poeder en oplosmiddel voor oplossing voor injectieBioMarin International Limited
- CzechiaVOXZOGOBioMarin International Limited, Dublin
- FinlandVoxzogoBiomarin International Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Voxzogo
- Liechtenstein · Voxzogo
- Norway · Voxzogo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dfe79a44-9e67-48ef-84ee-4793f41e13fc GET /v1/drugs/dfe79a44-9e67-48ef-84ee-4793f41e13fc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EMA",
"EPAR",
"Dispensbeslut"
],
"se_npl_id": "20200724000025",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20200724000025",
"product_doc_link": "https://www.ema.europa.eu/en/medicines/human/EPAR/voxzogo"
}See everything about vosoritide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.